Latinos and Alzheimer’s research: Addressing underrepresentation
- Embed recruitment and research operations within Latino communities and settings.
- Creatively address limited literacy in English and Spanish.
- Make binding all diversity plans at the Food and Drug Administration for AD/ADRD (Alzheimer’s disease and Alzheimer’s disease related dementias) clinical trials.
- Support national legislation promoting trial participation of underrepresented groups.
Source: Read Full Article